We are live on
!
Find out more
Royal London Asset Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+29.41%
3 Year Est. Return
+102.29%
5 Year Est. Return
+137.02%
10 Year Est. Return
–
AUM
$9.77B
AUM Growth
-$175M
(-1.8%)
Cap. Flow
-$808M
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
586
New
6
Increased
102
Reduced
329
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$173M |
| 2 |
Core Laboratories
CLB
|
+$170M |
| 3 |
Everest Group
EG
|
+$87.1M |
| 4 |
RenaissanceRe
RNR
|
+$70.9M |
| 5 |
Royal Caribbean
RCL
|
+$69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$161M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$109M |
| 3 |
Chevron
CVX
|
+$99.7M |
| 4 |
Verizon
VZ
|
+$89.4M |
| 5 |
Boeing
BA
|
+$77.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.99% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.32% |
| 4 | Consumer Discretionary | 13.05% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$223B
| $43.1M | 0.44% |
176,630
+3,481
| +2% | +$801K |
|
52
Qualcomm
QCOM
$171B
| $42.7M | 0.44% |
593,002
-19,848
| -3% | -$1.31M |
|
53
Nike
NKE
$60.8B
| $42.6M | 0.44% |
502,370
-35,488
| -7% | -$2.85M |
|
54
Texas Instruments
TXN
$257B
| $42.1M | 0.43% |
392,002
-16,123
| -4% | -$1.79M |
|
55
RTX Corp
RTX
$302B
| $41.8M | 0.43% |
475,675
-18,928
| -4% | -$1.59M |
|
56
Gilead Sciences
GILD
$169B
| $41.7M | 0.43% |
540,125
-12,323
| -2% | -$931K |
|
57
Bunge Global
BG
$21.5B
| $39M | 0.4% |
286,670
+226,619
| +377% | +$15M |
|
58
US Bancorp
USB
$100B
| $39M | 0.4% |
737,782
-7,191
| -1% | -$381K |
|
59
GE Aerospace
GE
$382B
| $38.9M | 0.4% |
719,062
-34,504
| -5% | -$2.13M |
|
60
American Express
AXP
$231B
| $38.8M | 0.4% |
364,646
-20,318
| -5% | -$2.11M |
|
61
Lowe's Companies
LOW
$124B
| $38M | 0.39% |
330,900
-15,299
| -4% | -$1.59M |
|
62
ConocoPhillips
COP
$151B
| $35.9M | 0.37% |
463,819
-22,170
| -5% | -$1.6M |
|
63
SLB Ltd
SLB
$79.3B
| $35.5M | 0.36% |
583,158
-5,422
| -0.9% | -$349K |
|
|
CELG
64
DELISTED
Celgene Corp
CELG
| $35M | 0.36% |
390,612
+79,817
| +26% | +$7.05M |
|
|
RTN
65
DELISTED
Raytheon Company
RTN
| $34.8M | 0.36% |
168,429
+1,849
| +1% | +$368K |
|
66
Goldman Sachs
GS
$302B
| $34.5M | 0.35% |
153,933
+1,930
| +1% | +$449K |
|
67
Lockheed Martin
LMT
$137B
| $34.3M | 0.35% |
99,176
-4,813
| -5% | -$1.55M |
|
68
Allegion
ALLE
$14.3B
| $33.7M | 0.34% |
468,806
+369,901
| +374% | +$31.2M |
|
69
CVS Health
CVS
$120B
| $33.7M | 0.34% |
427,686
-3,936
| -0.9% | -$281K |
|
70
Illumina
ILMN
$29B
| $32.9M | 0.34% |
92,239
+30,028
| +48% | +$9.62M |
|
71
United Parcel Service
UPS
$88.5B
| $32.2M | 0.33% |
275,867
-9,978
| -3% | -$1.17M |
|
72
Invesco
IVZ
$14B
| $31.6M | 0.32% |
271,744
+106,649
| +65% | +$2.67M |
|
73
NextEra Energy
NEE
$179B
| $31.6M | 0.32% |
753,012
-36,236
| -5% | -$1.54M |
|
74
Biogen
BIIB
$30.4B
| $31.3M | 0.32% |
88,668
-2,702
| -3% | -$930K |
|
75
Intuitive Surgical
ISRG
$141B
| $30.8M | 0.32% |
161,235
+23,058
| +17% | +$4.09M |
|
Similar funds
TI
RIM
LP
Royal London Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Royal London Asset Management held 586 positions worth $9.77B, down 1.8% from $9.94B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Royal London Asset Management withdrew a net $808M in Q3 2018, closing 73 positions and reducing 329 holdings. Its most notable exit was JPMorgan Chase, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Royal London Asset Management opened a new position in Abiomed Inc worth $7.25M.
- Royal London Asset Management's largest Q3 2018 buy was Abiomed Inc: 16,122 shares worth $7.25M.
- Royal London Asset Management added most to NXP Semiconductors in Q3 2018, an estimated $173M increase.
- Royal London Asset Management's biggest Q3 2018 reduction was Apple, cutting an estimated $24.5M.
- Royal London Asset Management fully exited JPMorgan Chase in Q3 2018, selling an estimated $161M.
- Royal London Asset Management's ten largest holdings make up 25% of its $9.77B portfolio in Q3 2018.
- Royal London Asset Management opened 6 new positions and closed 73 in Q3 2018.
- Royal London Asset Management's portfolio value fell 1.8% quarter-over-quarter to $9.77B.
Based on Royal London Asset Management's 13F filing for Q3 2018, filed 8 Nov 2018.